Empagliflozin

DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica

DMF submissions from China jump 42% as India continues to top list in Q1 2024

Generic drugs play a crucial role in providing access to life-saving drugs at affordable prices. To

Top Pharma Companies & Drugs in 2023: Merck’s Keytruda emerges as top-selling drug; Novo, Lilly sales skyrocket

The pharma industry clearly recalibrated itself in 2023, turning its focus away from Covid and onto

Endocrinology Newsmakers: Drugmakers work on triple agonist treatments, gene therapies to fight diabetes

Endocrinology, a medicinal branch that deals with endocrine and metabolic disorders, is witnessing

DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings

In 2022, the world finally began to emerge out of Covid-related restrictions. Though 2020 and 2021

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative

This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk

Singh bros hit back at Daiichi in Ranbaxy case; New drug shortages legislation in Canada

This week, Phispers brings you the latest twist in the Singh brothers-Daiichi 2008 Ranbaxy sell-off

Venture capitalist likely to head USFDA; Layoffs at Sanofi, Lilly, Mylan, AstraZeneca and Endo

This week, Phispers brings you news on the probable new head of the US FDA. Meanwhile, pharma biggie

US and EU compete on regulatory vigor; former chiefs seek elevation of status for FDA

This week, Phispers reports on Sanofi and Boehringer Ingelheim’s asset swap, a possible cure f